Valeant Pharmaceuticals International Inc. is repurchasing $1.45 billion of its outstanding senior notes in tender offers.
The Canadian drugmaker noted that about $364.7 million in notes were tendered out of $660.5 million of outstanding 6.375% senior notes due 2020. About $1.02 billion in notes are expected to be accepted for purchase out of $1.71 billion of outstanding 5.375% senior notes maturing 2020. Meanwhile, $72.5 million in notes were tendered out of $650.0 million of outstanding 6.750% senior notes due 2021.
Valeant expects to accept for purchase all the notes validly tendered before March 23, the early tender date, subject to certain conditions. The conditions to the tender offers are expected to be satisfied as of March 26.
The tender offers will expire at 11:59 p.m. ET on April 9.
Deutsche Bank Securities is acting as the dealer manager in the tender offers. Global Bondholder Services Corp. has been retained to serve as both the depositary and the information agent for the offers.